BNR - Company ID 0001792267
The table below shows Burning Rock Biotech Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $77.16M | $70.67M | $75.70M | $81.66M | $79.69M | $65.89M |
| Cost of revenue | $19.54M | $21.02M | $24.54M | $26.56M | $22.55M | $17.77M |
| Gross profit | $57.62M | $49.65M | $51.16M | $55.10M | $57.14M | $48.11M |
| R&D | $23.81M | $31.82M | $48.88M | $61.16M | $57.73M | $40.45M |
Burning Rock Biotech Ltd reported annual revenue of $77.16M for fiscal year 2025. That is up 9.2% from $70.67M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $65.89M (FY 2020) to $77.16M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $18.03M |
| $35.84M |
| $61.67M |
| $82.39M |
| $76.93M |
| $45.03M |
| Operating income | -$7.84M | -$48.99M | -$94.27M | -$142.15M | -$125.08M | -$63.20M |
| Income tax | $223.00K | $806.00K | $336.00K | $288.00K | $141.00K | $0.00 |
| Net income | -$7.92M | -$47.49M | -$92.07M | -$140.81M | -$125.02M | -$62.41M |
| EPS (diluted) | - | - | - | - | - | - |